Clinical Trials Browser

Recruiting × BRCA1 Mutation × 30 days × Clear all

NCT06177171 2026-05-27

Olaparib and ASTX727 in BRCA1/2- and Homologous Recombination Deficient (HRD)-Mutated Tumors

Phase 1 Recruiting

BRCA1 Mutation